Navigation Links
Antihistamine Proved Ineffective in Making Kids to Sleep

Antihistamines used to put young children sleep was found ineffective – researchers from Georgetown University Medical Center reports//.

Study suggested that children (under age 2) who received diphenhydramine drug showed no benefits from its effectiveness.

In fact, the national study, conducted by researchers from Georgetown University Medical Center and published in the July issue of Archives of Pediatrics & Adolescent Medicine, found that the drug appeared to perform worse than a placebo agent. Only 1 out of 22 children showed improvement in sleeping after using diphenhydramine compared to 3 in 22 children who used a placebo. The drug, an antihistamine, is available over-the-counter in generic forms or as the name-brand drug, Benadryl?.

Because of diphenhydramine's obvious lack of effectiveness, the clinical trial's Data Safety Monitoring Board shut down the study early, says lead author, Dan Merenstein, M.D., an assistant professor in the Department of Family Medicine at Georgetown.

‘This is a small study, but one with big implications, because it is looking at the effectiveness of a widely used drug that has not been examined for infant and toddler use,’ says Merenstein. Half of pediatricians recommend use of diphenhydramine, according to surveys, and many child-rearing books offer the same advice, ‘but because the drug works as a sleep aide for some adults, we pretend it works for everyone,’ he says.

Merenstein cautions that a larger study is needed to definitively prove that diphenhydramine doesn't work as thought in young children, but adds, ‘At this point I would advise parents to think about different methods to help a child sleep,’ Merenstein says.

Researchers at Johns Hopkins University, Virginia Fairfax University, and the University of Hawaii worked with Merenstein on the study, which he conducted at Johns Hopkins before coming to Georgetown.

The clinical trial, known as TIRED (Tri al of Infant Response to Diphenhydramine), enrolled 44 children, age 6-15 months, with the participation of their parents, and followed the families for six weeks. During this time, parents kept diaries to record the sleep habits of their children throughout the night. Treatment with a placebo agent or diphenhydramine occurred during one week, and the days before and after treatment were recorded for comparison purposes. The study was blinded in that neither researchers nor parents knew which children received which treatment.

The investigators had hypothesized that, based on the sedative properties of diphenhydramine in adults, treated children would be more likely to fall asleep without any other help from their parents, and that doing so would lead them to associate the crib with sleep and comfort, helping them to fall back asleep if they woke up.

But Merenstein says the results were surprising. Diphenhydramine use was no more effective than a placebo in reducing nighttime awakening, ‘or improving overall parental happiness with sleep for infants,’ he says.

Merenstein also notes that while it is generally reported about 7 percent of diphenhydramine users become ‘hyperactive,’ and so have increased sleep problems, only one child showed some evidence of hyperactivity. Still, he says, ‘it is possible that diphenhydramine caused low-level hyperactivity in children, negating the sleep benefits seen in some adults, but we really don't know why it didn't work.’

‘The bottom line here is that parents and pediatricians should rely on evidence-based medicine and not on leaps of logic that border on folklore,’ Merenstein says.

Sourc: Eurekalert
'"/>




Related medicine news :

1. Nasal Spray Beats Antihistamine
2. Antihistamine Could also be used as a Potential Antimalarial Drug
3. Travelers’ Hazard- Antihistamines Make Drowsy Driver
4. Plastic Sling Has Proved Successful In Improving Aging Of The Neck
5. Non Hormonal Therapies for Menopause Not Proved to be Effective
6. An After-Dinner Nap Is A Natural Thing, Scientists Proved
7. Womb Transplants are Possible - Research Proved
8. Preventive Measures Proved Ineffective in Allergic Children
9. Anti-Glycolytic Therapy Proved to be Effective Against Tumors
10. Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure
11. Aspirin and other NSAIDS Proved Less Effective in Long-Term Smokers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: